Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody.
about
Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia.Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity.Detection of measles virus-specific immunoglobulin M in dried venous blood samples by using a commercial enzyme immunoassayPerformance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measlesMumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays.Measles seropositivity in HIV-infected Kenyan children on antiretroviral therapy.Immune response to 1 and 2 dose regimens of measles vaccine in Pakistani childrenLong-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults.Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccineMeasles virus-specific antibody levels in individuals in Argentina who received a one-dose vaccineSystemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth.Immunoglobulin G avidity testing in serum and cerebrospinal fluid for analysis of measles virus infection.Profiling of measles-specific humoral immunity in individuals following two doses of MMR vaccine using proteome microarrays.Susceptibility to Measles Among Perinatally HIV-Infected Adolescents and Young Adults.Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.Assessment of immunoglobulin M enzyme immunoassays for diagnosis of measles.Assessment of measles immunity among infants in Maputo City, MozambiquePerformance Evaluation of the VIDAS(®) Measles IgG Assay and Its Diagnostic Value for Measuring IgG Antibody Avidity in Measles Virus Infection.Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles/MMR immunization programmeCalibration and Evaluation of Quantitative Antibody Titers for Measles Virus by Using the BioPlex 2200.Highly individual patterns of virus-immune IgG effector responses in humans.Sustained Responses to Measles Revaccination at 24 Months in HIV-Infected Children on Antiretroviral Therapy in Kenya.Measles and Rubella Seroprevalence Among HIV-infected and Uninfected Zambian Youth.Low immunity to measles and rubella among female guest workers, northern Mariana Islands.Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination.
P2860
Q31107510-D0F0CCE2-773E-4B20-B477-626340DD209AQ33659393-A91AAA39-7E6A-443F-8A74-6E049CE516AEQ33946428-8ACF8156-C236-4913-B388-28F466B9E050Q33964845-C9DC2813-4F26-47B3-9D40-2A4A360632F6Q34042075-A5163480-65D0-4DAD-B394-532FD03153DFQ34161077-0061AB5E-97E4-47DD-A3E4-72FB7E754F4DQ34169995-88E78821-3D9F-49CC-B081-23DC8EEAF05BQ34775950-824B82C1-7DDF-412A-8A74-16712AEFDC15Q34996026-7B094663-F040-4C4A-8F10-9CDFD69E058DQ35051541-42F71FEB-961A-4129-BAD4-D296C35D8BCDQ35073039-11D4921D-8D64-4D4E-BDB4-E677BFBD1A51Q35073868-85B60377-193D-4C8C-AF75-515ABD6F72F8Q35226116-48A298C7-AAE6-4358-843D-B51573C0EC51Q35232801-0F65C440-83E2-4C20-976A-60D14D076A3BQ35239262-479FD991-CEBD-44A2-BC51-2F643451F236Q36746957-A70AB869-9717-435B-9573-76ACA966D77BQ36891783-DE4E149A-FB79-443D-8443-98FA7518A5AAQ37072915-D8F3651D-71A6-4C80-B1DB-F8682EE48C42Q37203193-2589F950-25D0-48B9-BB4E-66D2ADE902CCQ37387174-B27B0A0F-813A-4701-BEE3-50CF8E6F3158Q37563593-96DAC14A-B53A-48B8-AC86-126577CCF97EQ38953491-87D845AE-C002-427D-8B6B-A94F2DCA276EQ38960642-83DF2DD7-C9AB-4CAF-9082-77DADB7D8F37Q39159372-45BBCD8A-E509-4483-91B6-2193C5C3617FQ42832330-5B865BB4-822D-4D90-939B-BAEED4436CEEQ45422417-2AE2F19F-2259-4342-A6A1-8B69AC91CB8F
P2860
Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Comparison of commercial enzym ...... ion of measles virus antibody.
@ast
Comparison of commercial enzym ...... ion of measles virus antibody.
@en
type
label
Comparison of commercial enzym ...... ion of measles virus antibody.
@ast
Comparison of commercial enzym ...... ion of measles virus antibody.
@en
prefLabel
Comparison of commercial enzym ...... ion of measles virus antibody.
@ast
Comparison of commercial enzym ...... ion of measles virus antibody.
@en
P2093
P2860
P1476
Comparison of commercial enzym ...... ion of measles virus antibody.
@en
P2093
Bouilianne N
P2860
P304
P407
P577
1995-04-01T00:00:00Z